Ju-Seog Lee

21PUBLICATIONS
43CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jun 03, 2026
TGF-β1 and TGF-β2 family members differentially modulate tumor initiation and invasiveness of primary liver cancer in a MMP14-dependent manner.

|Apr 10, 2026
Proliferation and Apoptosis Adaptor Protein 15 (PEA15), a Potential Oncogenic Regulator of VHL and HIF1A Identified through Proteomic Analysis in Hepatocellular Carcinoma.

Yun Seong Jeong, Ji-Hyun Shin, Soo Mi Kim

|Jan 10, 2026
Evolving Molecular Subtypes of Gastric Cancer: From Past Classifications to Present Consensus and Future Directions for Precision Therapy.

Ju-Seog Lee

|Jul 28, 2025
Hepatic Metabolic Signature and Its Association with the Response to Immunotherapy in Hepatocellular Carcinoma.

Hyewon Park, Sowon Park, Kena Park

|Jun 10, 2024
PARP-1 selectively impairs <i>KRAS</i>-driven phenotypic and molecular features in intrahepatic cholangiocarcinoma.

Friederike L Keggenhoff, Darko Castven, Diana Becker

|Jun 02, 2023
Reply: Consensus subtypes of HCC associated with clinical outcomes and genomic phenotypes.

Sun Young Yim, Ju-Seog Lee

Pageof 4

Frequent Collaborators

5 joint publications

Hyun-Sung Lee

4 joint publications

Yong Sun Lee

3 joint publications

Seon-Young Kim

2 joint publications

Myoung-Hee Kang